Orthofix Medical Income Statement (2010-2026) | OFIX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	121.39M	112.43M	70.14M	106.42M	118.07M	114.00M	122.23M	162.25M	187.02M	184.01M	200.41M	188.61M	185.42M	196.61M	254.20M	193.65M	203.12M	205.63M	255.47M	196.71M
Cost of Revenue (Quarter)	27.44M	28.31M	33.25M	28.32M	31.60M	30.57M	33.05M	64.88M	67.47M	64.24M	63.78M	61.37M	63.87M	61.55M	66.82M	72.03M	63.59M	57.11M	63.57M	57.16M
Gross Profit (Quarter)	93.95M	84.12M	91.81M	78.10M	86.47M	83.42M	89.18M	110.33M	119.55M	119.76M	136.63M	127.24M	134.75M	135.05M	148.84M	121.62M	139.53M	148.52M	156.34M	139.55M
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	57.34M	56.10M	-114.60M	11.21M	59.89M	11.94M	-120.42M	23.31M	99.25M	94.95M	-207.76M	19.49M	18.05M	17.29M	18.81M	19.77M	15.93M	14.77M	15.37M	15.32M
Selling, General & Administrative (Quarter)	18.34M	16.31M	18.26M	19.33M	15.85M	19.32M	254.28M	48.81M	34.18M	27.14M	420.27M	131.69M	134.22M	130.14M	136.48M	132.98M	136.49M	148.10M	136.75M	134.91M
Restructuring Costs (Quarter)								18.20M	0.26M	-0.09M	1.01M	2.21M	5.35M	0.51M	1.31M
Other Operating Expenses (Quarter)								0.47M	1.29M	3.85M	-20.06M	2.26M	-0.28M	8.34M	-26.09M	3.04M	4.03M	21.55M	-62.41M	2.92M
Operating Expenses (Quarter)	75.67M	72.41M	-96.34M	30.54M	75.73M	31.27M	133.86M	90.32M	11.20M	9.55M	213.52M	153.39M	11.23M	10.89M	156.60M	152.75M	152.43M	162.88M	152.13M	150.23M
Operating Income (Quarter)	4.27M	-0.31M	-9.35M	-3.08M	6.64M	-5.79M	-11.04M	-59.71M	-36.63M	-24.45M	-18.32M	-29.34M	-24.91M	-18.90M	-11.48M	-48.87M	-16.00M	-17.05M	0.49M	-14.44M
EBIT (Quarter)	4.27M	-0.31M	-9.35M	-3.08M	6.64M	-5.79M	-11.04M	-59.71M	-36.63M	-24.45M	-18.32M	-29.34M	-24.91M	-18.90M	-11.48M	-48.87M	-16.00M	-17.05M	0.49M	-14.44M
Non-operating items
Non Operating Investment Income (Quarter)										0.43M	1.35M	-0.26M	1.81M	3.57M			-0.03M	-0.01M	-0.01M	-0.02M
Interest & Investment Income (Quarter)	0.10M	0.51M	-0.83M	-0.67M	0.16M	-0.24M	1.14M	-0.06M	0.38M	-0.31M	-1.34M	1.67M
Other Non Operating Income (Quarter)	0.95M	-1.79M	4.01M	1.24M	-3.19M	-3.31M	7.91M	-0.58M	-0.27M	1.91M	1.97M	1.59M	0.85M	-1.18M	-3.31M	-1.04M	5.73M	-0.54M	-9.35M	-0.73M
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	4.67M	-0.21M	-3.62M	-4.39M	-1.66M	-9.37M	-6.99M	-60.33M	-37.92M	-1.75M	-22.05M	0.63M	-32.36M	-26.64M	-29.71M	-52.13M	3.46M	-22.26M	-2.19M	-20.83M
Tax Provisions (Quarter)	0.02M	0.13M	-2.81M	0.07M	0.55M	1.34M	-1.14M	0.61M	1.51M	0.47M	0.12M	0.85M	1.08M	0.75M	-2.45M	0.96M	-0.14M	0.53M	-1.05M	0.07M
Profit After Tax (Quarter)	2.42M	-2.17M	-1.26M	-1.16M	2.49M	-13.06M	3.79M	-60.94M	0.84M	-1.75M	-150.91M	0.63M	-33.44M	-25.56M	-29.15M	1.75M	-14.08M	-23.07M	-2.22M	-21.38M
Income from Continuing Operations (Quarter)	4.64M	-0.33M	-0.81M	-4.46M	-2.21M	-10.72M	-5.84M	-60.94M	-39.43M	-2.22M	-22.17M	-0.22M	-33.44M	-27.39M	-27.26M	-53.09M	3.61M	-22.80M	-1.14M	-20.91M
Income from Discontinued Operations (Quarter)
Consolidated Net Income (Quarter)	4.64M	-0.33M	-0.81M	-4.46M	-2.21M	-10.72M	-5.84M	-60.94M	-39.43M	-2.22M	-22.17M	-0.22M	-33.44M	-27.39M	-27.26M	-53.09M	3.61M	-22.80M	-1.14M	-20.91M
Income towards Parent Company (Quarter)	4.64M	-0.33M	-0.81M	-4.46M	-2.21M	-10.72M	-5.84M	-60.94M	-39.43M	-2.22M	-22.17M	-0.22M	-33.44M	-27.39M	-27.26M	-53.09M	3.61M	-22.80M	-1.14M	-20.91M
Net Income towards Common Stockholders (Quarter)	4.64M	-0.33M	-0.81M	-4.46M	-2.21M	-10.72M	-5.84M	-60.94M	-39.43M	-2.22M	-22.17M	-0.22M	-33.44M	-27.39M	-27.26M	-53.09M	3.61M	-22.80M	-1.14M	-20.91M
Additional items
EPS (Basic) (Quarter)	0.24	-0.02	-0.04	-0.22	-110.43	-533.37	-0.29	-0.00M	-0.00M	-59.71	-0.60	-5.78	-879.62	-0.71	-0.71	-1.35	0.09	-0.57	-0.03	-0.52
EPS (Diluted) (Quarter)	0.23	-0.02	-0.04	-0.22	-109.98	-533.37	-0.29	-0.00M	-0.00M	-59.71	-0.60	-5.78	-879.62	-0.71	-0.71	-1.35	0.09	-0.57	-0.03	-0.52
Shares Outstanding (Quarter)	19.65M	19.77M	19.69M	19.90M	0.02M	0.02M	20.05M	0.04M	0.04M	0.04M	36.73M	0.04M	0.04M	38.49M	38.13M	39.19M	39.50M	39.77M	39.60M	40.45M
Shares Outstanding (Diluted) (Quarter)	19.94M	19.77M	19.69M	19.90M	0.02M	0.02M	20.05M	0.04M	0.04M	0.04M	36.73M	0.04M	0.04M	38.49M	38.13M	39.19M	39.50M	39.77M	39.60M	40.45M
EBITDA (Quarter)	12.78M	5.05M	41.60M	7.11M	11.42M	14.26M	35.17M	3.20M	21.12M	23.07M	32.34M	18.40M	27.87M	30.07M	35.68M	19.49M	28.92M	32.53M	37.91M	17.73M
Interest Expenses (Quarter)	1.18M	1.14M	1.16M	1.07M	1.00M	0.93M	0.30M	1.67M	2.08M	1.79M	0.26M	2.75M	3.23M	3.05M	10.30M	2.37M	0.87M	0.82M	2.21M	2.21M
Tax Rate (Quarter)	0.51%	-62.14%	77.56%	-1.62%	-33.33%	-14.34%	16.36%	-1.01%	-3.98%	-26.94%	-0.57%	134.44%	-3.35%	-2.82%	8.24%	-1.84%	-4.10%	-2.39%	47.99%	-0.36%

Research Tools

Developers

Orthofix Medical Income Statement (2010-2026) | OFIX

Research Tools

Developers

Orthofix Medical Income Statement (2010-2026) | OFIX

Create an account

Sign In

Reset Password